Dr. Petricciani has held senior positions in the public and private sectors in clinical development and regulatory affairs. He is the former Senior Vice President, Medical and Regulatory Affairs at CancerVax Corporation; Vice President, Regulatory Affairs at Genetics Institute, Inc.; and Director of the Office of Biologics at the US Food and Drug Administration. Dr. Petricciani is the Immediate Past President of the International Association for Biologicals (IABS).

Dr. Ensley is the Chairman and CEO of DermaPlus Products and is on the faculties of the University of Arizona and Northern Arizona University.  Previously, Dr. Ensley was President and Vice President for Research of NuCycle Therapy, Inc. (as iBio, Inc. was formerly known), President and CEO of Phytotech, Inc. and headed the Specialty Chemicals Group at Amgen.  Dr. Ensley served a six-year term on the National Science Foundation's BIO Directorate Advisory Board.

Dr. Glück has successfully taken a novel adjuvanted delivery platform from concept to market, and has also been instrumental in the development of vaccines against rabies, mumps, measles and rubella. Dr. Glück is currently Executive Vice President, Research & Development, Vaccine Discovery for Crucell-Berna Biotech in Basel, Switzerland. He is also President of Etna Biotech and President of the Swiss Biotech Association. Dr. Glück was formerly a research scientist at Ciba-Geigy AG and a researcher at the University of Bern and holds a Ph.D. in Microbiology and Immunochemistry.

Dr. Hartman is the Vice President of Fraunhofer USA, Inc. He is responsible for the strategic growth and management of the five technology centers operated by the not-for-profit research organization throughout the United States. Dr. Hartman is a former Professor of Mechanics and Materials Science at Johns Hopkins University and has over twenty-five years of executive experience in the development and management of technological businesses.

Dr. Stanley Plotkin is one of the world’s leading experts in vaccinology. He is an Emeritus Professor of the University of Pennsylvania and Executive Advisor to sanofi pasteur. Over the course of his career, Dr. Plotkin has served as Senior Assistant Surgeon with the Epidemic Intelligence Service of the Centers for Disease Control; Director of the Division of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia; Professor of Pediatrics and Microbiology at the University of Pennsylvania; Professor of Virology at the Wistar Institute and Medical and Scientific Director of Pasteur-Mérieux-Connaught (now sanofi pasteur). Dr. Plotkin developed the rubella vaccine now in standard use throughout the world, and has worked extensively on the development and application of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus.

Dr. Russell is the Founding President and current Chairman of the Board of Trustees of the Sabin Vaccine Institute. He is Professor Emeritus of the Johns Hopkins School of Hygiene and Public Health, Department of International Health. Dr. Russell retired in 1990 from the U.S. Army as Major General after a distinguished career in infectious disease research and vaccine development. His military assignments included Director of the Walter Reed Army Institute of Research, and overseas tours in Pakistan, Thailand and Vietnam. In 2001, he was appointed as a Special Advisor in the Office of Public Health Preparedness where he directed the development and acquisition of biodefense vaccines and antitoxins for the Strategic National Stockpile under Project BioShield. Dr. Russell currently serves on the Board of Directors of the International AIDS Vaccine Initiative, is a member of the Strategic Advisory Committee of the Bill & Melinda Gates Children's Vaccine Program and is a consultant to the Bill & Melinda Gates Foundation.